Mortality in carotid sinus hypersensitivity: a cohort study
Joanna L Hampton1, Carol Brayne, Michelle Bradley
1Department of Geriatric Medicine, Addenbrookes Hospital, Cambridge, UK.
Insights
Carotid sinus hypersensitivity (CSH) in older adults does not increase mortality risk compared to the general population. Survival rates are similar across different CSH subtypes, confirming its neutral effect on lifespan.
Area of Science:
- Cardiology
- Geriatrics
- Epidemiology
Background:
- Carotid sinus hypersensitivity (CSH) is a prevalent condition in elderly individuals.
- Previous research suggests a potential link between CSH and increased mortality, warranting further investigation.
Purpose of the Study:
- To investigate the mortality rates of patients with CSH compared to a matched general population cohort.
- To determine if different subtypes of CSH are associated with varying survival outcomes.
Main Methods:
- A retrospective cohort study involving 1504 patients diagnosed with CSH between 1990 and 2001.
- Comparison of mortality data with geographically and age-matched controls from the Office of National Statistics.
- Analysis of survival curves using Kaplan-Meier methods and calculation of standardized mortality ratios (SMRs).
Main Results:
- No significant difference in all-cause, cerebrovascular, or cardiovascular mortality was observed between CSH patients and the general population (SMRs).
- Survival rates did not differ significantly among the three identified subtypes of CSH (p=0.2).
Conclusions:
- CSH is not associated with an increased risk of mortality in older adults.
- There is no evidence to suggest differential mortality risks based on CSH subtypes.
- These findings reinforce the understanding of CSH as having a neutral effect on overall mortality.
Abstract:
Objective Carotid sinus hypersensitivity (CSH) is common in older people. The authors hypothesise that patients with CSH have a higher mortality than a geographically, age-matched older cohort. Design A retrospective cohort study compared to geographical and age-matched data from the Office of National Statistics. Setting Specialist clinic in tertiary centre. Patients 1504 patients with CSH were identified from a single syncope outpatient assessment service between 1990 and 2001. Interventions Vital status was confirmed, and death certificates were sought for all deceased patients up to 2003. Main outcome measures Kaplan-Meier survival curves were analysed within the cohort according to three different subtypes of CSH. Standardised mortality rates (SMRs) were determined using geographical and age-matched data from the Office of National Statistics. Results There was no difference between CSH patients and the general population in SMRs for all causes, or for cerebrovascular or cardiovascular deaths. There was no difference in survival between the three subtypes of CSH (p=0.2) within the study cohort. Conclusion CSH is not associated with a higher mortality than the general population, and there are no differences in mortality between the three subtypes of CSH. This confirms earlier findings and reinforces the neutral effect of CSH on mortality.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
